Martinez, Jecelyn P.
HRN: 06-89-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/05/2023
CO-AMOXICLAV 625MG (TAB)
08/05/2023
08/10/2023
PO
1 Tab
BID
S/p NSVD W/ RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes